United States: Day 1 Notes On The 2019 JP Morgan Healthcare Conference

Last Updated: January 14 2019
Article by Eric A. Klein and Aytan Dahukey

Please Don't Poke the Baby – Sharing a best practice and talking about taking a local hospital learning and turning it into a systemwide approach, Mark Harrison of Intermountain Healthcare shared the fact that taking fewer blood samples from neonatal intensive care unit (NICU) babies was shown to lead to less infections in the NICU and on average a two week earlier discharge from the NICU. Who knew?

Drug Pricing – Drug pricing was on many lips today. Intermountain Healthcare launched Civica to address generic drug pricing and reported that it had approximately 500 hospital members now. More than one-third of US hospitals (!!) have inquired about joining Civica, which provides an exclamation point on the issue of generic drug pricing and availability. Mark Harrison of Intermountain said that products would start being available in 2019. He also noted that Civica doesn't have to produce pills if the generic manufacturers will engage appropriately. Teva predicted generic drug market stabilization in their presentation today, which was also noted in the Walgreens Boots presentation as well. Walgreens Boots thought that the pace of cost reduction has slowed though. Let's see who wins this game of "chicken." Also today, Northwell announced that they were launching their own pharmacy benefit management (PBM) operation. We expect to see a lot of realignment and new entries in the PBM space, given the recent mergers and other activity (CVS/Aetna, Cigna/ESI, Anthem/IngenioRx). Much of the PBM space is being rethought now as its scope can expand to chronic condition management (an objective highlighted by Cigna today) or to medical benefits management as ESI is hoping with its recent acquisition of eviCore.

SDOH, Guns and Food Insecurity – Multiple presenters addressed the impact of food insecurity, guns and the social determinants of health on health care status and costs. Bernard Tyson of Kaiser said that we have to address food insecurity in order to make meaningful gains in healthcare. His point is well taken if you look at how many Medicare and Medicaid patients are at or close to the poverty line nationally. Geisinger's presentation by Jaewon Ryu echoed that as well, sharing that its diabetes management program supplying fruits and vegetables to families of diabetic patients has reduced A1C scores by approximately 2 points (more than the average reduction on diabetes medication) and resulted in average cost savings of $12,000 per patient based on fewer emergency room visits and inpatient admissions. On the topic of guns, Tyson made it clear that the presence of guns needed to be confronted, given the number of gunshot wounds that Kaiser treats every day. Violence in our society and its impact on patients and the healthcare system was also a topic in the CommonSpirit presentation (Dignity Health and CHI). These items and other social determinants of health (SDOH), such as housing, need to gain more publicity, attention and resources if we are to bend the cost curve in healthcare. Mark Harrison of Intermountain was heartened by HHS Secretary Alex Azar recently signaling support for SDOH funding and we will wait to see next steps on this initiative from the federal government (once it reopens).

Physician Organization Partnering – While not a new topic, one of the focus areas today was the beneficial results of tight affiliations with physician organizations. Humana's presentation repeatedly mentioned their joint ventures and relationships with JenCare and Iora Health, as well as discussing their attempt to consolidate and build a brand around Conviva, which aggregates their employed physician businesses in Florida and Texas into a professional services entity and management services organization (MSO) multiple organization to consolidate and improve clinical approaches, management infrastructure and branding. Humana also has its proprietary primary care offering, Partners in Primary Care.

Why does this matter? Here's two reasons: (1) Humana is focused on reducing avoidable senior hospital admissions per thousand (which they consider a key statistic) by 10 to 30 admissions per thousand, each point of which reduction is equivalent nationally per Humana to $35 million in cost reduction (and therefore profit improvement); and (2) Humana's medical expense ratio (MER; also known as medical loss ratio (MLR)) drops by "hundreds of basis points" when unmanaged care is transformed into full risk-bearing reimbursement structures managed by effective physician organizations. Per Humana, risk works. Cigna also emphasized the importance of alignment and shared that 85% of its Medicare Advantage business is in some form of value-based arrangement now.

The acquisition of physicians by health system also is continuing, although the discussion now is focused on what can be done with those acquired and employed physicians. Many health systems are losing money directly on their physicians, but they are critical overall to the health of the health system. Interestingly, Northwestern in Chicago noted today that 80% of its health system revenue can be traced to its employed physician groups.

Medicaid – Notwithstanding the current uncertainties surrounding the Affordable Care Act from the recent Texas federal court decision in Texas v. Azar, the Medicaid market was portrayed generally positively at the conference today. Centene remains bullish, forecasting growth and maintaining its earnings guidance, and noted that the addressable market for Medicaid is large and growing. Centene's CEO also noted their focus on process automation and cost reduction. He also focused on a strong opportunity to use technology to better manage drug spend and pharmacy benefit management (PBM). Interestingly, he also mentioned that Centene was preparing to move away from or be less reliant on PBM rebate structures. Given that the recent CMS pronouncements did not follow through on the Office of Management and Budget consideration of rethinking rebates, as was disclosed last year, this appears to be very forward thinking and in part may be driven by the desire for greater transparency and data driven decision making.

Humana's CFO also focused in part on the Medicaid market in his remarks today, noting that there is a large opportunity for Humana to use their Medicare Advantage "chassis" for serving the dual eligible population. Humana is focused initially on the Florida and Texas markets, and, reading between the lines, there may be an appetite for a Medicaid acquisition to grow to scale. Humana also noted an opportunity with DSNPs, especially as state and federal coordination continues in this sector.

Cancer – A big market, and getting bigger as we have longer lifespans and more seniors, cancer was very much framed today as a significant opportunity. Whether it was CommonSpirit noting that they had 12 million patients with cancer in their two ministries right now and were committed to their precision medicine initiative to apply genomics to drug selection or Intermountain's Navican that focuses on oncology precision medicine, improving cancer care was very much a topic of interest today. We have seen a good deal of activity in the oncology space recently, including the recent launch of One Oncology by private equity fund General Atlantic, several leading oncology medical groups and oncology EMR provider Flatiron Health.

Revenue Cycle Management – Lots of good news on the revenue cycle management (RCM) front today. Intermountain reported very positive results from its recent enterprise wide outsourcing/partnering transaction with R1 RCM last year. Significant performance improvements and jobs were saved. Similarly, Bon Secours Mercy Health shone a spotlight on their Ensemble Health Partners RCM enterprise today. CEO John Starcher reported that Ensemble, which had been acquired two years ago with $10 million in EBITDA, now was heading toward $90 million in EBITDA and was one of the most profitable units in the health system.

ACA, Remember That? – While ACA – exchange products and pricing and Medicaid expansion – was a hot topic at prior JP Morgan conferences, it was pretty much ignored or just folded into a routine discussion of product lines. No discussion of the Texas federal case, Texas v. Azar, or potential Congressional actions in any of the presentations we attended today, nor any wringing of hands or gnashing of teeth. Guess we've moved on...

View our Day 2 notes on the 2019 JP Morgan Healthcare Conference.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Events from this Firm
22 Oct 2019, Roundtable, Los Angeles, United States

Please join us for Sheppard Mullin's Ethics and Eggs: A Breakfast Roundtable to Discuss Ethics Issues in IP Matters.

23 Oct 2019, Other, Dallas, United States

Marketing Wants To Do What? Sweepstakes, Influencers, Loyalty, and Other Advertising and Promotional Fun

25 Oct 2019, Webinar, Los Angeles, United States

Matthew Bonovich will be a speaker at this webinar.

State and local governments continue to incentivize renewable energy and battery storage, causing an increase in mergers and acquisitions among producers and specialized renewables.

 
In association with
Related Topics
 
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions